These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events.
    Author: Hsu CY, Hsu RK.
    Journal: Ann Intern Med; 2022 Sep; 175(9):JC105. PubMed ID: 36063554.
    Abstract:
    Lv J, Wong MG, Hladunewich MA, et al. Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2022;327:1888-98. 35579642.
    [Abstract] [Full Text] [Related] [New Search]